AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ
Holding GB:0HFQ?
Track your performance easily

AnaptysBio (0HFQ) Financial Statements

0 Followers

AnaptysBio Financial Overview

AnaptysBio's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AnaptysBio is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-1.71. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 10.97M$ 7.18M$ 9.01M$ 3.32M$ 3.46M
Gross Profit$ 10.97M$ 7.18M$ 9.01M$ 3.32M$ 3.46M
EBIT$ -46.65M$ -37.62M$ -42.22M$ -37.31M$ -39.84M
EBITDA$ -46.06M$ -37.01M$ -34.24M$ -39.71M$ -41.44M
Net Income Common Stockholders$ -46.66M$ -43.94M$ -42.21M$ -37.31M$ -39.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 350.80M$ 354.67M$ 390.90M$ 413.05M$ 429.49M
Total Assets$ 427.38M$ 405.83M$ 452.39M$ 487.33M$ 517.10M
Total Debt$ 16.95M$ 17.39M$ 17.81M$ 18.23M$ 18.65M
Net Debt$ -333.86M$ -337.28M$ -373.09M$ -394.81M$ -410.83M
Total Liabilities$ 417.50M$ 358.06M$ 364.29M$ 366.94M$ 368.65M
Stockholders Equity$ 9.88M$ 47.78M$ 88.10M$ 120.38M$ 148.45M
Cash Flow-
Free Cash Flow$ -21.36M$ -37.28M$ -34.63M$ -36.64M$ -25.60M
Operating Cash Flow$ -21.32M$ -37.25M$ -34.35M$ -36.47M$ -25.41M
Investing Cash Flow$ -2.44M$ 68.62M$ 49.18M$ 30.64M$ -20.45M
Financing Cash Flow$ 41.89M$ -13.63M$ -5.16M$ -3.07M$ -13.49M
Currency in USD

AnaptysBio Earnings and Revenue History

AnaptysBio Debt to Assets

AnaptysBio Cash Flow

AnaptysBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis